• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE

Drugs for Parkinson’s and Alzheimer’s

August 27, 2018Alzheimer's, Nervous System Disorders, Parkinson's, Vizit Graphs
Drugs for Parkinson’s and Alzheimer’s

Find drugs common to both Parkinson’s and Alzheimer’s diseases using Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

CANCER TP53 CD4 CELL PROLIFERATION SOD1 ESCHERICHIA COLI RECEPTOR BREAST CANCER STAPHYLOCOCCUS AUREUS APOPTOTIC PROCESS TH17 CELLS PARKINSON DISEASE CLOSTRIDIUM DIFFICILE PORPHYROMONAS GINGIVALIS NEURODEGENERATIVE DISORDERS IL17A CELL DIVISION IFNG IMMUNE RESPONSE CTLA4 IL23A AGING REMICADE CELL DEATH ANGIOGENESIS FOXP3 LISTERIA MONOCYTOGENES AUTOPHAGY METFORMIN ALZHEIMER'S DISEASE STREPTOCOCCUS PNEUMONIAE CANDIDA ALBICANS CASP3 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE RHEUMATOID ARTHRITIS PSEUDOMONAS AERUGINOSA TNF INSULIN ERBB-2 DOXORUBICIN INFLAMMATION CELL DIFFERENTIATION HELICOBACTER PYLORI DIABETES MELLITUS IL6

© 2019 Biovista Vizit All Rights Reserved.